跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alfree - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Alfree
Approved
STANDARD
Alfree
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a33e26f0e4c3346d
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
a33e26f0e4c3346d
Drug Approval Philippines Name
Alfree
Product Name
Alfree
Registration Number
DRP-9074
Brand Name
Alfree
Generic Name
Cetirizine dihydrochloride
Dosage Form
Solution (Oral Drops)
Dosage Strength
10 mg/ mL
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
24 January 2025
Expiry Date
17 August 2030
Pharmacologic Category
Antihistamine (Piperazine Derivative)
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a33e26f0e4c3346d
Type
Standard
Back to Philippines FDA Approvals